doi:10.1186/2008-2231-22-49 Souri E, Donyayi H, Ahmadkhaniha R, Tehrani MB (2015) A stability indicating HPLC method for the determination of fluvoxamine in pharmaceutical dosage forms
This can be stated given the particular counteracting effect on convulsions (i.e., insulin hypoglycemic convulsions [62], and paracetamol over-dose-convulsions, progressive hepatic encephalopathy with generalized convulsions [61]), the improved conscious/unconscious/death ratio in trauma brain injury mice [78], attenuated/counteracted cerebellar ataxia, fore and hind limbs disabilities in cuprizone rats [80], and counteracted sedation/unconsciousness (diclofenac [108], ibuprofen [107])
National Library of Medicine.
UPLYFT does not provide dosing, administration, or human-use guidance
(I went for the private blood test at the hospital rather than pin prick myself) Lol